Rituximab preferentially eliminates BCR signaling proficient chronic lymphocytic leukemia B cells In Vivo

Investor logo

Warning

This publication doesn't include Faculty of Medicine. It includes Central European Institute of Technology. Official publication website can be found on muni.cz.

Authors

PAVLASOVÁ Gabriela BORSKÝ Marek MUSILOVÁ Kateřina ŠEDA Václav ČERNÁ Kateřina OSIČKOVÁ Jitka VOJÁČKOVÁ Eva BRYCHTOVÁ Yvona DOUBEK Michael POSPÍŠILOVÁ Šárka MAYER Jiří MRÁZ Marek

Year of publication 2016
Type Conference abstract
MU Faculty or unit

Central European Institute of Technology

Citation
Related projects:

You are running an old browser version. We recommend updating your browser to its latest version.

More info